NeoCart Trials Outcomes Boost Histogenics (HSGX); Surprise Growth for Applied Optoelectronics (AAOI)
Histogenics Corp. (Nasdaq:HSGX) shares soared more than 35% in after-hours trading Wednesday as the company said that follow-up MRI (magnetic resonance imaging) data through 5-years from Phase 1 & 2 studies showed that patients with articular knee cartilage lesions that were treated with its investigational tissue-engineered implant NeoCart presented a significant improvement in cartilage quality.
HSGX stock finished the regular session in negative territory by 1.30% (or -$0.02) at $1.52 with a total volume of 535,788 shares traded, representing a large increase in activity versus its average volume (3m) of 97,616 shares
Histogenics, which focuses on developing and commercializing products in the musculoskeletal segment of the marketplace, has 15.93M shares outstanding and HSGX stock 52-week range is from $1.39 to $4.47 per share. At close on Wednesday, the regenerative medicine company had a market capitalization of $23.75M.
Shares of Applied Optoelectronics Inc. (Nasdaq:AAOI) climbed over 17% to near their 52-week high levels in the extended session Wednesday after the company delivered in its preliminary quarterly financial results profit and revenue numbers well-above analysts’ expectations.
For the fourth quarter 2016, Applied Optoelectronics expects revenue to be between $84.5 million and $84.8 million, and non-GAAP net income of between $0.77 and $0.82 per diluted share, exceeding the company’s prior outlook of revenue in the range of $75.0 million to $79.0 million and non-GAAP net income in the range of $0.46 to $0.51 per diluted share, also easily surpassing the Capital IQ Consensus Estimate of $0.50 earnings per share on revenues of $77.51 million for the period.
AAOI stock closed at $22.72, down $0.15 (or -0.66%) and 382,462 of its shares changed hands during the day.
Applied Optoelectronics, which designs, manufactures, and sells fiber-optic networking products, has 17.20M shares outstanding, market capitalization (intraday) of $390.74M and AAOI stock one-year range is between $8.08 and $27.28 per share
Disclaimer: The disclaimer is to be read and fully understood before using our site, or joining our email list. GalaxyStocks is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read full disclaimer at http://galaxystocks.com/disclaimer/